Astex Pharmaceuticals

Astex Pharmaceuticals is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the CNS. Astex is developing a proprietary pipeline of novel therapies and has multiple partnered products in development, including three approved drugs from its collaborations with leading pharmaceutical companies.

Astex’s industry-leading fragment-based drug discovery capability is continually advancing through cutting-edge innovations in Cryo-EM, Informatics, and machine learning/AI-driven modelling - powered by one of the largest proprietary datasets of protein-ligand structures, to accelerate the development of next-generation therapeutics.

Astex is a wholly owned subsidiary of Otsuka Pharmaceutical Co Ltd, based in Tokyo, Japan

For more information about Astex Pharmaceuticals, visit its website.